ISSN: 2168-9296
+44 1478 350008
Xuehua Xu
Chemotaxis Signal Section, Laboratory of Immunogenetics
NIH/NIAID, 12441 Parklawn Drive, Rockville, MD, USA
Dr. Xuehua Xu obtained her bachelor’s and master’s degrees in biology from Harbin Normal University, China, and her PhD in biotechnology from Tsukuba University, Japan. Starting in 2002, Dr. Xu was in postdoctoral training at the National Institutes of Health (NIAID/NIH), where she focused on developing and applying state-of-the-art imaging technologies to monitor the signaling network of GPCR-mediated chemotaxis in the model organism Dictyostelium discoideum. The interplay between computational simulation and experimental verification allowed her to identify new components and novel signaling pathways essential for chemotaxis. In 2006, she was recruited as an assistant professor at the Georgetown University School of Medicine. She further expanded her research from the model organism to mammalian neutrophils and breast cancer. In 2010, she was recruited to NIH as a staff scientist. Her research focuses on understanding the molecular mechanisms of GPCR-mediated chemotaxis in multiple systems and identifying new therapeutic strategies for inflammatory diseases and metastasis of breast cancer.
Her research focuses on understanding the molecular mechanisms of GPCR-mediated chemotaxis in multiple systems and identifying new therapeutic strategies for inflammatory diseases and metastasis of breast cancer.